Shane Aaron Johnson serves as Executive at InMed Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Shane Aaron Johnson has executed 3 insider transactions totaling $28.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 6, 2022 involved purchasing 8,500 shares valued at $10.7K.
Shane Aaron Johnson currently holds 304,595 shares of InMed Pharmaceuticals Inc. (INM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shane Aaron Johnson has been a net buyer of INM stock. They have purchased $28.3K and sold $0 worth of shares.
Shane Aaron Johnson's most recent insider trade was on Jan 6, 2022, when they purchased 8,500 shares at $1.26 per share.
Get notified when new Form 4 filings are submitted
| $1.33 |
| Discretionary |
| Nov 15, 2021 | INM | $6.8K | Purchase | 5,000 | $1.37 | Discretionary |